CLAIRE HOPPENOT to Female
This is a "connection" page, showing publications CLAIRE HOPPENOT has written about Female.
Connection Strength
0.227
-
Gaps in patient-physician communication at the time of malignant bowel obstruction from recurrent gynecologic cancer: a qualitative study. Support Care Cancer. 2022 Jan; 30(1):367-376.
Score: 0.030
-
Top Ten Tips Palliative Care Clinicians Should Know About Caring for Patients with Cervical Cancer. J Palliat Med. 2021 03; 24(3):438-442.
Score: 0.029
-
Approach to Palliative Care Consultation for Patients With Malignant Bowel Obstruction in Gynecologic Oncology: A Qualitative Analysis of Physician Perspectives. JCO Oncol Pract. 2020 08; 16(8):483-489.
Score: 0.028
-
Malignant bowel obstruction due to uterine or ovarian cancer: Are there differences in outcome? Gynecol Oncol. 2019 07; 154(1):177-182.
Score: 0.026
-
Who are the long-term survivors of high grade serous ovarian cancer? Gynecol Oncol. 2018 01; 148(1):204-212.
Score: 0.023
-
Follow-Up After Molar Pregnancy Evacuation: Feasibility of Using Semi-Quantitative Urine Pregnancy Tests. J Reprod Med. 2016 May-Jun; 61(5-6):192-6.
Score: 0.021
-
Sonographic evaluation for intra-abdominal hemorrhage after cesarean delivery. J Clin Ultrasound. 2016 May; 44(4):240-4.
Score: 0.020
-
Cervical cancer screening in high- and low-resource countries: implications and new developments. Obstet Gynecol Surv. 2012 Oct; 67(10):658-67.
Score: 0.016
-
Self-Collection for Primary HPV Testing: Acceptability in a Large Urban Emergency Department. Ann Emerg Med. 2025 Mar; 85(3):249-257.
Score: 0.010
-
Herpesvirus Infection Masquerading as a Neoplasm in an HIV-Positive Patient: A Potential Diagnostic Pitfall. Am J Dermatopathol. 2023 May 01; 45(5):333-336.
Score: 0.009
-
Outcomes after targeted treatment based on somatic tumor genetic testing for women with gynecologic cancers. Gynecol Oncol. 2021 11; 163(2):220-228.
Score: 0.008
-
The road to long-term survival: Surgical approach and longitudinal treatments of long-term survivors of advanced-stage serous ovarian cancer. Gynecol Oncol. 2019 02; 152(2):228-234.
Score: 0.006